Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2026-02-21 @ 12:41 AM
Study NCT ID:
NCT03644550
Status:
TERMINATED
Last Update Posted:
2021-12-02
First Post:
2018-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma
Sponsor:
National Cancer Institute (NCI)
Organization: